Erasca Company
Erasca is a developer of oncology drugs intended to provide precision oncology options.
Investors
.png)
Founded Date:
2018-01-01
Total Funding:
400000000.0
Investor Type:
IPO
Employee Number:
101-250
Funding Status:
IPO
Technology:
Biotechnology, Life Science
Last Funding Type:
Post-IPO Equity
Investors Number:
12.0
Last Funding Date:
2022-12-09
Industry:
Medical BioTech
Headquarters:
San Diego, California, United States
Estimated Revenue:
$1M to $10M